Published in Biochem Biophys Res Commun on January 16, 1989
Endothelium-dependent vascular responses. Mediators and mechanisms. J Clin Invest (1989) 1.36
Contractile activity of three endothelins (ET-1, ET-2 and ET-3) on the human isolated bronchus. Br J Pharmacol (1990) 1.20
Endothelin receptor is coupled to phospholipase C via a pertussis toxin-insensitive guanine nucleotide-binding regulatory protein in vascular smooth muscle cells. J Clin Invest (1990) 1.16
Effects of endothelin on the mechanical activity and cytosolic calcium level of various types of smooth muscle. Br J Pharmacol (1989) 1.16
Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells. Biochem J (1990) 1.16
Modulation of the [Ca2+] sensitivity of myosin phosphorylation in intact swine arterial smooth muscle. J Physiol (1990) 1.16
Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway. J Clin Invest (1990) 1.11
Endothelin augments unitary calcium channel currents on the smooth muscle cell membrane of guinea-pig portal vein. J Physiol (1990) 1.06
Stimulation of the hydrolysis of phosphatidylinositol 4,5-bisphosphate and phosphatidylcholine by endothelin, a complete mitogen for Rat-1 fibroblasts. Biochem J (1990) 1.06
Mechanism of endothelin-induced contraction in guinea-pig trachea: comparison with rat aorta. Br J Pharmacol (1990) 1.05
Endothelin-1-induced [3H]-inositol phosphate accumulation in rat trachea. Br J Pharmacol (1992) 0.96
Evidence for receptor-mediated bivalent-cation entry in A10 vascular smooth-muscle cells. Biochem J (1990) 0.96
Endothelin as an autocrine factor in the regulation of parathyroid cells. Proc Natl Acad Sci U S A (1991) 0.95
A comparative study of endothelin- and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells. Biochem J (1992) 0.95
Response of rabbit ear artery to endothelin-1 during cooling. Br J Pharmacol (1991) 0.94
Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest (1991) 0.92
Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J Clin Invest (1989) 0.91
Contraction of rat thoracic aorta strips by endothelin-1 in the absence of extracellular Ca2+. Br J Pharmacol (1991) 0.87
Influence of endothelin 1 on human atrial myocardium--myocardial function and subcellular pathways. Basic Res Cardiol (1996) 0.85
Multiple sources of calcium for contraction of the human urinary bladder muscle. Br J Pharmacol (1989) 0.85
Participation of protein kinase C in endothelin-1-induced contraction in rat aorta: studies with a new tool, calphostin C. Br J Pharmacol (1992) 0.85
Endothelin 1 stimulates Ca2+-sparks and oscillations in retinal arteriolar myocytes via IP3R and RyR-dependent Ca2+ release. Invest Ophthalmol Vis Sci (2011) 0.84
ET-1-associated vasomotion and vasospasm in lymphatic vessels of the guinea-pig mesentery. Br J Pharmacol (2003) 0.84
Reactivity and sensitivity of mesenteric vascular beds and aortic rings of spontaneously hypertensive rats to endothelin: effects of calcium entry blockers. Br J Pharmacol (1990) 0.81
Modulation of endothelin-1-induced contractions by magnesium/calcium in porcine ciliary arteries. Graefes Arch Clin Exp Ophthalmol (1998) 0.81
Cell-to-cell communication via nitric oxide modulation of oscillatory Cl(-) currents in rat intact cerebral arterioles. J Physiol (2001) 0.80
Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium. Br J Pharmacol (1996) 0.79
Receptor-linked early events induced by vasoactive intestinal contractor (VIC) on neuroblastoma and vascular smooth-muscle cells. Biochem J (1990) 0.79
Involvement of ETA receptors in the facilitation by endothelin-1 of non-adrenergic non-cholinergic transmission in the rat urinary bladder. Br J Pharmacol (1994) 0.78
Control of coronary blood flow by autacoids. Basic Res Cardiol (1995) 0.78
Nifedipine and experimental cardioprotection. Cardiovasc Drugs Ther (1990) 0.77
Regional modulation of cyclic nucleotides by endothelin-1 in rat pulmonary arteries: direct activation of G(i)2-protein in the main pulmonary artery. Br J Pharmacol (2000) 0.75
Endothelin: a new vasoactive ocular peptide. Br J Ophthalmol (1992) 0.75
Effect of cromakalim (BRL 34915) on hemodynamic and electrocardiographic changes induced by endothelin in dogs. Basic Res Cardiol (1991) 0.75
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med (2001) 6.22
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol (1981) 4.75
The relationship between peritubular capillary protein concentration and fluid reabsorption by the renal proximal tubule. J Clin Invest (1969) 3.39
The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med (1982) 3.13
Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol (1987) 3.06
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest (1985) 2.99
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest (1986) 2.96
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest (1986) 2.91
Nephron adaptation to renal injury or ablation. Am J Physiol (1985) 2.65
Molecular basis of proteinuria of glomerular origin. N Engl J Med (1978) 2.61
Dynamics of glomerular ultrafiltration in the rat. IV. Determination of the ultrafiltration coefficient. J Clin Invest (1973) 2.55
Diverse biological actions of atrial natriuretic peptide. Physiol Rev (1990) 2.42
Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int (1981) 2.36
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. Diabetologia (2010) 2.35
Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem (1986) 2.33
Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci U S A (1994) 2.32
A model of glomerular ultrafiltration in the rat. Am J Physiol (1972) 2.32
The dynamics of glomerular ultrafiltration in the rat. J Clin Invest (1971) 2.27
The relationship between glomerular filtration rate and sodium reabsorption by the proximal tubule of the rat nephron. J Clin Invest (1968) 2.27
Dynamics of glomerular ultrafiltration in the rat. II. Plasma-flow dependence of GFR. Am J Physiol (1972) 2.24
Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter. Proc Natl Acad Sci U S A (1993) 2.15
Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex. Am J Physiol (1976) 2.01
Influence of postglomerular hematocrit and protein concentration on rat nephron fluid transfer. Am J Physiol (1971) 1.97
Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest (1991) 1.96
Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol (1993) 1.92
Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde. Anal Biochem (1978) 1.89
Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int (1982) 1.86
Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A (1985) 1.85
Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions. Kidney Int (1975) 1.83
Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int (2006) 1.80
Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int (2000) 1.74
Relationship between extracellular volume and fluid reabsorption by the rat nephron. Am J Physiol (1969) 1.74
ROMK inwardly rectifying ATP-sensitive K+ channel. II. Cloning and distribution of alternative forms. Am J Physiol (1995) 1.72
Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. Cancer Res (2001) 1.69
Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res (1975) 1.69
Neutralizing TGF-beta1 antibody infusion in neonatal rat delays in vivo glomerular capillary formation 1. Kidney Int (1999) 1.66
Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int (1983) 1.65
An inhibitory effect of furosemide on sodium reabsorption by the proximal tubule of the rat nephron. J Clin Invest (1969) 1.65
Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran. Biophys J (1975) 1.64
Dynamics of glomerular ultrafiltration in the rat. 3. Hemodynamics and autoregulation. Am J Physiol (1972) 1.63
Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism. J Exp Med (1990) 1.62
Dynamics of glomerular ultrafiltration in the rat. VII. Response to reduced renal mass. Am J Physiol (1974) 1.62
Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int (1981) 1.62
Vasoconstriction: a new activity for platelet-derived growth factor. Science (1986) 1.61
Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest (1983) 1.60
Phorbol ester and 1-oleoyl-2-acetylglycerol inhibit angiotensin activation of phospholipase C in cultured vascular smooth muscle cells. J Biol Chem (1985) 1.57
Micropuncture study of nephron function in the rhesus monkey. J Clin Invest (1968) 1.55
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest (1984) 1.55
Permselectivity of the glomerular capillary wall. Facilitated filtration of circulating polycations. J Clin Invest (1978) 1.53
Glomerular endothelial cells respond to calcium-mobilizing agonists with release of EDRF. Am J Physiol (1990) 1.51
Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am J Med (1986) 1.50
Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am J Physiol (1992) 1.50
Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules. J Clin Invest (1977) 1.46
Effects of aging on the renal glomerulus. Am J Med (1986) 1.44
Heteroporous model of glomerular size selectivity: application to normal and nephrotic humans. Am J Physiol (1985) 1.44
Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest (1997) 1.43
Determinants of glomerular filtration in experimental glomerulonephritis in the rat. J Clin Invest (1975) 1.42
Determination of glomerular size-selectivity in the normal rat with Ficoll. J Am Soc Nephrol (1992) 1.42
Oncotic and hydrostatic pressures in peritubular capillaries and fluid reabsorption by proximal tubule. Am J Physiol (1971) 1.42
Postglomerular vascular protein concentration: evidence for a causal role in governing fluid reabsorption and glomerulotublar balance by the renal proximal tubule. J Clin Invest (1971) 1.41
Quantitative assessment of proximal tubule function in single nephrons of the rat kidney. Am J Physiol (1971) 1.41
Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J Biol Chem (2001) 1.40
Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies. Arch Biochem Biophys (1993) 1.39
Renal risk scores: progress and prospects. Kidney Int (2008) 1.38
Determinants of glomerular permselectivity: Insights derived from observations in vivo. Kidney Int (1977) 1.38
Biologically active atrial peptides. J Clin Invest (1985) 1.37
Endothelium-dependent vascular responses. Mediators and mechanisms. J Clin Invest (1989) 1.36
Nitric oxide synthesis in endothelial cells: evidence for a pathway inducible by TNF-alpha. Am J Physiol (1991) 1.35
Endothelin, a peptide inhibitor of Na(+)-K(+)-ATPase in intact renaltubular epithelial cells. Am J Physiol (1989) 1.35
Phorbol ester-induced contraction of arterial smooth muscle and inhibition of alpha-adrenergic response. Biochem Biophys Res Commun (1984) 1.35
Congenital oligonephropathy: The fetal flaw in essential hypertension? Kidney Int Suppl (1996) 1.35
Angiotensin II-stimulated Na+/H+ exchange in cultured vascular smooth muscle cells. Evidence for protein kinase C-dependent and -independent pathways. J Biol Chem (1987) 1.31
Influence of molecular configuration on the passage of macromolecules across the glomerular capillary wall. J Gen Physiol (1979) 1.30
Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. Kidney Int (2006) 1.30
Arachidonic acid metabolism, prostaglandins and the kidney. Am J Med (1982) 1.30
Permselectivity of the glomerular capillary wall to macromolecules. I. Theoretical considerations. Biophys J (1975) 1.30
A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions. J Biol Chem (2000) 1.29
Fewer nephrons at birth: a missing link in the etiology of essential hypertension? Am J Kidney Dis (1995) 1.29
Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate. J Clin Invest (1976) 1.27
Comparative renal effects of isoncotic and colloid-free volume expansion in the rat. Am J Physiol (1972) 1.26
Hormonal modulation of glomerular function. Am J Physiol (1983) 1.26
Pressures in cortical structures of the rat kidney. Am J Physiol (1972) 1.25
Glomerular permselectivity: barrier function based on discrimination of molecular size and charge. Am J Physiol (1978) 1.25
Early experience with dual kidney transplantation in adults using expanded donor criteria. Double Kidney Transplant Group (DKG). J Am Soc Nephrol (1999) 1.25
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. J Am Soc Nephrol (2001) 1.24
Angiotensin increases inositol trisphosphate and calcium in vascular smooth muscle. Hypertension (1985) 1.24
Short stature and diabetic nephropathy. BMJ (1995) 1.24
Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol (1977) 1.23
George E. Brown memorial lecture. Role of atrial peptides in body fluid homeostasis. Circ Res (1986) 1.23
Early agonist-mediated ionic events in cultured vascular smooth muscle cells. Calcium mobilization is associated with intracellular acidification. J Biol Chem (1987) 1.22
Hypertension and proteinuria: long-term sequelae of uninephrectomy in humans. Kidney Int (1984) 1.22
Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol (1989) 1.20
Pathophysiology of altered glomerular function in aminoglycoside-treated rats. Kidney Int (1981) 1.20
A model of peritubular capillary control of isotonic fluid reabsorption by the renal proximal tubule. Biophys J (1973) 1.19
Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction. J Clin Invest (1985) 1.19
cGMP mediates effects of atrial peptides on medullary collecting duct cells. Am J Physiol (1987) 1.18